Overview:
A solid tumor is an abnormal mass of tissue that normally does not contain any cysts or liquid areas. The tumor can sometimes be benign (non-cancerous) or malignant (cancer). The tumors are categorized on the basis of the cell type into sarcomas, lymphomas and carcinomas. The solid tumors can be observed in many places such as organs, muscle and bone. There are different therapies to treat solid tumors including prevention of tumor and combination of surgery, radiation therapy and chemotherapy. The market of solid tumors treatment is witnessing introduction of new types of treatment.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/793
Drivers:
Increasing cases of solid tumors is expected boost growth of the global solid tumors treatment market. For instance, in 2011, the International Journal of Pharma Sciences and Research (IJPSR) reported that in 2015, cancer caused around 9 million deaths, the number is expected to increase to 11.4 million by 2030. Among this solid tumors caused maximum prevalence of cancer.
Furthermore, growing inclination towards use of biosimilars treatment is also expected to augment growth of the global solid tumors treatment market. For instance, solid tumors treatment comprised some biologics such as, MabThera, Erbitux, Herceptin, and Avastin. These biosimilars have some advantages that help overcome the limits of generic drugs in the solid tumors treatment.
Restraints:
Factors such as high cost of cancer therapy, increasing drug patent cliff and greater volume of generic therapeutic products, strict rules and regulations for manufacturing of drugs are expected to hamper growth of the global solid tumors treatment market. For instance, the government of India implemented regulations in late 2012, where the cap prices were put on 348 drugs on Essential Drug List (EDL), and drug manufacturers are required to follow the regulations by keeping the drug cost under the ceiling price.
Market Taxonomy:
The global solid tumors treatment market is divided by therapy, by the end user, by application, and by region.
By therapy:
-
Radiotherapy
-
Immunotherapy
-
Chemotherapy
-
Targeted therapy
-
Hormone therapy
By end users:
-
Cancer treatment centers
-
Hospitals
By application:
-
Breast cancer
-
Lung cancer
-
Colorectal cancer
-
Prostate cancer
-
Cervical cancer
-
others
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/793
Regional Analysis:
The Solid Tumors Treatment market is regionally divided into North America, Latin America, Europe, Asia Pacific, Africa, and the Middle East.
North America is expected to witness significant growth in the solid tumors treatment market owing to increasing prevalence of solid tumor cases and presence of robust healthcare infrastructure. For instance, in 2013, the Centers for Disease Control and Prevention (CDC) reported that breast cancer affected around 230,815 women and 2109 men in the U.S.
Moreover, Asia Pacific is expected to witness robust growth in the solid tumors treatment market attributed to growing healthcare expenditure, medical tourism, increasing budget of people and growing number of patients.
Major players:
Major players functioning in the solid tumors treatment market are Biogen Idec Incorporated, Johnson & Johnson Company, Bristol Myers Squibb Company, Sanofi, Abbott Laboratories Inc., AstraZeneca Plc., Amgen Inc., GlaxoSmithKline Plc., and Baxter International Incorporated.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/793
Table of Content
Global Solid Tumors Treatment Market Research Report
Section 1: Global Solid Tumors Treatment Industry Overview
Section 2: Global Economic Impact on Solid Tumors Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Solid Tumors Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Solid Tumors Treatment Market Forecast
Other Reports:
Neuroendovascular Coils Market
Charcot-Marie-Tooth Disease Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
